Pancreatic enzyme supplementation

Heather A. Wier; Robert J. Kuhn

doi:10.1097/MOP.0b013e32834a1b33

Pancreatic enzyme supplementation

Heather A. Wier
, Robert J. Kuhn

Producción científica: Review article › revisión exhaustiva

14 Citas (Scopus)

Resumen

These new preparations, Creon, Zenpep, and Pancreaze, demonstrated improvement in the absorption of fat and nitrogen in patients with pancreatic insufficiency related to cystic fibrosis. Some patient variability to response continues, so clinicians need to continue to titrate dose and preparations based on weight gain and patient response.

Idioma original	English
Páginas (desde-hasta)	541-544
Número de páginas	4
Publicación	Current Opinion in Pediatrics
Volumen	23
N.º	5
DOI	https://doi.org/10.1097/MOP.0b013e32834a1b33
Estado	Published - oct 2011

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Acceder al documento

10.1097/MOP.0b013e32834a1b33

Otros archivos y enlaces

Citar esto

@article{200a0427df4c44cab8e292f59899c2fb,

title = "Pancreatic enzyme supplementation",

abstract = "These new preparations, Creon, Zenpep, and Pancreaze, demonstrated improvement in the absorption of fat and nitrogen in patients with pancreatic insufficiency related to cystic fibrosis. Some patient variability to response continues, so clinicians need to continue to titrate dose and preparations based on weight gain and patient response.",

keywords = "cystic fibrosis, fat absorption, pancreatic enzyme replacement therapy",

author = "Wier, \{Heather A.\} and Kuhn, \{Robert J.\}",

year = "2011",

month = oct,

doi = "10.1097/MOP.0b013e32834a1b33",

language = "English",

volume = "23",

pages = "541--544",

number = "5",

}

TY - JOUR

T1 - Pancreatic enzyme supplementation

AU - Wier, Heather A.

AU - Kuhn, Robert J.

PY - 2011/10

Y1 - 2011/10

N2 - These new preparations, Creon, Zenpep, and Pancreaze, demonstrated improvement in the absorption of fat and nitrogen in patients with pancreatic insufficiency related to cystic fibrosis. Some patient variability to response continues, so clinicians need to continue to titrate dose and preparations based on weight gain and patient response.

AB - These new preparations, Creon, Zenpep, and Pancreaze, demonstrated improvement in the absorption of fat and nitrogen in patients with pancreatic insufficiency related to cystic fibrosis. Some patient variability to response continues, so clinicians need to continue to titrate dose and preparations based on weight gain and patient response.

KW - cystic fibrosis

KW - fat absorption

KW - pancreatic enzyme replacement therapy

UR - https://www.scopus.com/pages/publications/80052688614

UR - https://www.scopus.com/pages/publications/80052688614#tab=citedBy

U2 - 10.1097/MOP.0b013e32834a1b33

DO - 10.1097/MOP.0b013e32834a1b33

M3 - Review article

C2 - 21799412

AN - SCOPUS:80052688614

SN - 1040-8703

VL - 23

SP - 541

EP - 544

JO - Current Opinion in Pediatrics

JF - Current Opinion in Pediatrics

IS - 5

ER -

Pancreatic enzyme supplementation

Resumen

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto